Saturday, August 1, 2015

Who knew? Glaxo donates N.C. Wyeth painting to the Philadelphia Museum of Art

The Philadelphia Museum of Art announced Tuesday that the drugmaker donated a painting called The Trial of the Bow by artist N.C. Wyeth that was hanging on a wall in the company's Franklin Square office for years without drawing much attention.

Who knew? Glaxo donates N.C. Wyeth painting to the Philadelphia Museum of Art

0 comments

Who knew?

Apparently not most of the folks at GlaxoSmithKline.

The Philadelphia Museum of Art announced Tuesday that the drugmaker donated a painting called The Trial of the Bow by artist N.C. Wyeth that was hanging on a wall in the company's Franklin Square office for years without drawing much attention.

An Inquirer story on this by Stephan Salisbury can be found here.

Glaxo is based in London, but has operations in several spots in the Philadelphia region. Some of its ancestor companies go back decades in Philadelphia.

Wyeth made 16 in a series in 1929 for a new edition of Homer's "The Odyssey." Wyeth sold the series to a private collector in 1930, but the whereabouts of 10 of the 16 are unknown.

Glaxo realized what it had when it was taking inventory prior to its move to the Navy Yard and had the art work in the Franklin Square office appraised. The Navy Yard building is new, but has a lot of glass and few walls suitable for hanging art.

 

0 comments
We encourage respectful comments but reserve the right to delete anything that doesn't contribute to an engaging dialogue.
Help us moderate this thread by flagging comments that violate our guidelines.

Comment policy:

Philly.com comments are intended to be civil, friendly conversations. Please treat other participants with respect and in a way that you would want to be treated. You are responsible for what you say. And please, stay on topic. If you see an objectionable post, please report it to us using the "Report Abuse" option.

Please note that comments are monitored by Philly.com staff. We reserve the right at all times to remove any information or materials that are unlawful, threatening, abusive, libelous, defamatory, obscene, vulgar, pornographic, profane, indecent or otherwise objectionable. Personal attacks, especially on other participants, are not permitted. We reserve the right to permanently block any user who violates these terms and conditions.

Additionally comments that are long, have multiple paragraph breaks, include code, or include hyperlinks may not be posted.

Read 0 comments
 
comments powered by Disqus
About this blog
David Sell blogs about the region's pharmaceutical industry. Follow him on Facebook.

For Inquirer.com. Portions of this blog may also be found in the Inquirer's Sunday Health Section.

Reach David at dsell@phillynews.com.

David Sell
Also on Philly.com:
letter icon Newsletter